ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.802,06
-0,19%
S&P 500
5.291,34
0,15%
US Dollar vs BRL
5,2865
0,69%
Bitcoin
70.426,49
2,36%
Brent Oil
77,185
-1,22%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) Notícias

FBIO Fortress Biotech Inc

1,84
-0,05 (-2,65%)
Após o horário de negociação
Última atualização: 17:00:15
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Fortress Biotech Inc FBIO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,05 -2,65% 1,84 17:00:15
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,88 1,82 1,89 1,84 1,89
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/05/202409:30GLOBEAvenue Therapeutics Announces Last Patient Last Visit in..
16/05/202409:00GLOBEFortress Biotech to Participate in the Alliance Global..
15/05/202417:15GLOBEFortress Biotech Reports First Quarter 2024 Financial..
15/05/202417:01GLOBEJourney Medical Corporation to Participate in the Alliance..
15/05/202409:30GLOBEAvenue Therapeutics Reports First Quarter 2024 Financial..
14/05/202409:30GLOBEFortress Biotech Announces First Patient Dosed in..
13/05/202417:01GLOBEJourney Medical Corporation Reports First Quarter 2024..
07/05/202409:30GLOBEJourney Medical Corporation to Announce First Quarter 2024..
02/05/202417:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
01/05/202417:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as Chief..
29/04/202421:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
29/04/202409:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
25/04/202409:30GLOBEJourney Medical Corporation to Present at the Planet..
24/04/202408:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
28/03/202417:05GLOBEFortress Biotech Reports 2023 Financial Results and Recent..
28/03/202410:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
25/03/202409:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
21/03/202417:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
18/03/202417:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
18/03/202409:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
15/03/202409:30GLOBEJourney Medical Corporation to Announce Year End 2023..
15/03/202409:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
13/03/202409:30GLOBEJourney Medical Corporation to Participate in the 36th..
12/03/202409:30GLOBEFortress Biotech to Participate in 36th Annual ROTH..
11/03/202409:30GLOBEJourney Medical Corporation Announces Presentation of Data..
11/03/202409:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
07/03/202409:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
04/03/202410:30GLOBEFortress Biotech and Cyprium Therapeutics Announce $4.1..
22/02/202410:30GLOBEAvenue Therapeutics Announces Publication in Drug..
11/01/202410:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
11/01/202410:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
05/01/202411:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
05/01/202410:30GLOBEJourney Medical Corporation Submits New Drug Application to..
04/01/202410:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
03/01/202418:01GLOBEFortress Biotech Announces Closing of $11 Million Registered..
02/01/202418:05GLOBEJourney Medical Corporation Secures Credit Facility with SWK..
02/01/202410:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
29/12/202310:20GLOBEFortress Biotech Announces Pricing of $11 Million Registered..
11/12/202310:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
06/12/202310:30GLOBECyprium Therapeutics, a Fortress Biotech Subsidiary Company,..
06/12/202310:30PRNUSSentynl Therapeutics Completes Asset Transfer of CUTX-101..
06/12/202310:00GLOBEJourney Medical Corporation Announces Successful Completion..
01/12/202310:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
14/11/202318:10GLOBEFortress Biotech Reports Third Quarter 2023 Financial..
14/11/202318:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
14/11/202318:01GLOBEFortress Biotech Announces Closing of $10.0 Million Public..
13/11/202318:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
10/11/202310:15GLOBEFortress Biotech Announces Pricing of $10.0 Million Public..
09/11/202319:05GLOBEFortress Biotech Announces Launch of Proposed Public..
07/11/202318:01GLOBEJourney Medical Corporation Reports Third Quarter 2023..

Seu Histórico Recente

NASDAQ
FBIO
Fortress Biotech
NYSE
ECVT
Ecovyst
BIT
P1TXB1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados